Advanced Search

Extraction Form Preview:

Corticosteroid implants for chronic non-infectious uveitis 2016


Arm Name Suggestions

Arm Title Arm Description User Note
Fluocinolone acetonide
Dexamethasone intravitreous

Arm Details


...
...
...

...
...
...

...
...
...


Design Details and Enrollment








































































Outcome Name Suggestions

Outcome Title Note
Proportion of participants with a recurrence of uveitis Proportion of participants with a recurrence of uveitis at 6 months. We defined recurrence as any of the following: increase in vitreous haze by two or more steps above baseline; increase in anterior chamber cell by two or more steps above baseline; need
Mean difference in BCVA Mean difference in best-corrected distance visual acuity (BCVA) as measured by the Early Treatment of Diabetic Retinopathy Study (ETDRS) chart, Snellen chart, or Snellen equivalent.
Mean difference in quality of life Mean difference in quality of life (mean difference in any validated measures presented, e.g. National Eye Institute Visual Functioning Questionnaire (NEI-VFQ), 36-Item Short Form Health Survey (SF-36)).


Outcome Details







Yes
No
Baseline
One or more time points after baseline and ≤6 months
One or more time points after baseline >6 months and ≤12 months
One or more time points after baseline >12 months and ≤24 months
Other
(please specify):


Adverse Events

Arm or Total Title Description Proportion of adverse events
Fluocinolone acetonide
Dexamethasone intravitreous